Luminex Corporation (NASDAQ: LMNX) today announced that it has received CE-IVD marking for its NxTAG® Respiratory Pathogen Panel. The Panel detects 21 clinically-relevant viral and bacterial ...

格隆汇12月17日丨诺唯赞(688105.SH)公布,公司六项呼吸道病原体核酸检测试剂盒于近日取得欧盟 CE IVDR 认证，可在欧盟国家和认可欧盟CE认证的国家进行销售。名称：Logilet Respiratory Pathogen Panel六项呼吸道病原体核酸检测试剂盒，预期用途：用于辅助诊断呼吸道合胞 ...

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that it has received 510(k) ...

CORALVILLE, Iowa--(BUSINESS WIRE)--To meet customer demand for a multiplexed, multiple respiratory disease target panel that provides comprehensive genome coverage, Integrated DNA Technologies (IDT) ...

Applied BioCode, a leader in innovative molecular diagnostic solutions, announced today the submission of a new nucleic acid extraction claim for the KingFisher™ Flex Nucleic Acid Purification System ...

SANTA FE SPRINGS, Calif., December 22, 2025--(BUSINESS WIRE)--Applied BioCode, a leader in innovative molecular diagnostic solutions, announced today the submission of a new nucleic acid extraction ...

CARLSBAD, Calif., June 29, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced that its ePlex® ...

New ready-to-ship xGen™ NGS solution will enable researchers to combat challenging diseases of today and prepare for the next pathogen of tomorrow Integrated DNA Technologies is revealing a new next ...

Viral panel is designed to test for eight pathogens in up to 96 patients. FDA granted 510(k) approval to Luminex’ xTAG Respiratory Viral Panel FAST (RVP FAST) test for respiratory infections. Designed ...

New York, NY, and Tel Aviv, ISRAEL , Aug. 10, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today ...

Rothia species, a group of gram‐positive bacteria normally residing in the oral and upper respiratory tracts, have increasingly been recognised as emerging opportunistic pathogens. Although usually ...